Skip to main content

Relyvrio Side Effects

Generic name: sodium phenylbutyrate / taurursodiol

Medically reviewed by Drugs.com. Last updated on Sep 15, 2023.

Note: This document contains side effect information about sodium phenylbutyrate / taurursodiol. Some dosage forms listed on this page may not apply to the brand name Relyvrio.

Applies to sodium phenylbutyrate / taurursodiol: oral powder for suspension.

Serious side effects of Relyvrio

Along with its needed effects, sodium phenylbutyrate/taurursodiol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking sodium phenylbutyrate / taurursodiol:

More common

Other side effects of Relyvrio

Some side effects of sodium phenylbutyrate / taurursodiol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

For Healthcare Professionals

Applies to sodium phenylbutyrate / taurursodiol: oral powder for reconstitution.

Gastrointestinal

Very common (10% or more): Abdominal pain (21%), diarrhea (25%), nausea (18%), salivary hypersecretion (11%)[Ref]

General

The most common adverse reactions were diarrhea, abdominal pain, nausea, and upper respiratory tract infection. While gastrointestinal side effects occurred throughout the study duration, they were more common in the first three weeks of treatment.[Ref]

Nervous system

Common (1% to 10%): Dizziness[Ref]

Other

Very common (10% or more): Fatigue (12%)[Ref]

Respiratory

Very common (10% or more): Upper respiratory tract infection (18%)[Ref]

References

1. Product Information. Relyvrio (sodium phenylbutyrate-taurursodiol). Amylyx Pharmaceuticals. 2022;1.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.